Countdown:
Abstract submission due:
December 15, 2025
Abstract acceptance due:
February 15, 2026
Conference date:
April 17-19, 2026
-
General Chair
Peixin Dong
-
Email:
Sasidharan Sreenivasan
update time: 2025-08-20, views:
Sasidharan Sreenivasan obtained his Ph. D. in 2007 from Universiti Sains Malaysia, Malaysia. He was served as the Deputy Director at Institute for Research in Molecular Medicine, Universiti Sains Malaysia from 2019 till 2021. He has over 220 publications with a total impact factor of > 250 (With more than 6589 citations in Scopus and h-Index = 42), published 16 chapters in book with international publishers, as well as Keynote, Invited Speaker and Chair of International & National Congresses. Has been serving as an Editor, Editorial Board Member, reviewer of international journals and evaluator for national and international grants. He has been recognized nationally and internationally as an expert in Pharmacognosy, Pharmacology, and anticancer studies, especially those that involve the pharmacological activity of medicinal plants. He was selected as a Top Research Scientists Malaysia (TRSM) by the Academy of Sciences Malaysia (ASM) in the year of 2022. In 2020, 2021, 2022, and 2023, he was figured among the top two percent (2%) scientists in a global list compiled by the prestigious Standford University from the United States of America. He reviewed more than 574 (Publoans) manuscripts for international journals. In 2019, he was placed in the top 1% of reviewers in Pharmacology and Toxicology, Clinical Medicine, and Cross-Field on Publons global reviewer database, United States of America. His research interests include medicinal plants, miRNA, nanoparticle and their role in Health and Disease Management, particularly natural products and nanoparticles (Green Carbon Dots) based antimicrobial, antioxidant, and anticancer agent development and toxicity study in cellular, genomic and animal model.